Brief Title
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Brief Summary
Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT
scans of the whole body are performed at baseline, three months later, and six months after
that for a total of three combined scans in the first year. Subsequently, these combined
scans will be performed at 6-monthly intervals for a total of two combined scans per year.
Study Type
Observational
Condition
Ocular Melanoma
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
174
Start Date
June 2006
Completion Date
August 2012
Primary Completion Date
August 2012
Eligibility Criteria
Inclusion Criteria:
1. Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving
the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or
the part of the eye behind the iris).
2. Patients 18 years of age or older.
3. Patients able to give informed consent.
Exclusion Criteria:
1. Patients who refuse to participate in the study.
2. Patients who are unable to cooperate with or cannot undergo PET/CT scanning.
3. Patients who will be moving out of the area of UCLA during the ten years of this
study.
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Tara A McCannel, MD, PhD, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT00351728
Organization ID
UCLA IRB #05-04-016
Responsible Party
Sponsor
Study Sponsor
Jonsson Comprehensive Cancer Center
Study Sponsor
Tara A McCannel, MD, PhD, Principal Investigator, Jules Stein Eye Institute, UCLA
Verification Date
July 2016